(CNCL) Global X Enhanced S&P/TSX - Ratings and Ratios
Canadian, Equities, ETF, Covered, Calls
Description: CNCL Global X Enhanced S&P/TSX
The Global X Enhanced S&P/TSX60 Covered Call ETF (CNCL) is a Canadian equity ETF that employs a covered call strategy on the S&P/TSX 60 Index, comprising the 60 largest and most liquid Canadian stocks. This ETF is designed to generate additional income through the sale of call options on the underlying index.
By utilizing a covered call strategy, CNCL aims to provide a regular stream of income to investors, while still allowing for some potential upside participation in the underlying index. The ETFs investment objective is to provide long-term capital appreciation and income, making it suitable for investors seeking regular returns.
Given the current technical data, the ETF is trading at $20.21, above its 20-day SMA of $19.76, indicating a positive short-term trend. The 50-day and 200-day SMAs are at $19.25 and $19.05, respectively, suggesting a longer-term uptrend. The ATR of 0.10 (0.49%) indicates relatively low volatility. Based on these technical indicators, we can expect the ETF to continue its upward trajectory, potentially reaching $21.50 in the near term.
From a fundamental perspective, the ETFs AUM of $16.73M CAD is relatively small, which may impact its liquidity. However, the covered call strategy can help mitigate potential risks associated with smaller AUM. Considering the current market conditions and the ETFs investment objective, we forecast that CNCL will continue to attract investors seeking income-generating products, potentially leading to an increase in AUM and a further boost to its price.
Combining both technical and fundamental analysis, our forecast suggests that CNCL will continue to perform well in the short to medium term, driven by its covered call strategy and the overall positive trend in the Canadian equity market. We expect the ETFs price to reach $22.50 by the end of the next quarter, presenting a potential upside of 11.5% from current levels.
CNCL ETF Overview
Market Cap in USD | 12m |
Category | Canadian Equity |
IPO / Inception | 2023-07-05 |
CNCL ETF Ratings
Growth Rating | 61.0 |
Fundamental | - |
Dividend Rating | 64.0 |
Rel. Strength | 0.32 |
Analysts | - |
Fair Price Momentum | 22.93 CAD |
Fair Price DCF | - |
CNCL Dividends
Dividend Yield 12m | 10.36% |
Yield on Cost 5y | 13.41% |
Annual Growth 5y | 40.37% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CNCL Growth Ratios
Growth Correlation 3m | 96.6% |
Growth Correlation 12m | 80.8% |
Growth Correlation 5y | 95.7% |
CAGR 5y | 15.37% |
CAGR/Max DD 5y | 1.12 |
Sharpe Ratio 12m | 1.55 |
Alpha | 6.88 |
Beta | 0.569 |
Volatility | 11.93% |
Current Volume | 0.2k |
Average Volume 20d | 1.6k |
Stop Loss | 20.1 (-3.4%) |
What is the price of CNCL shares?
As of August 13, 2025, the stock is trading at CAD 20.80 with a total of 244 shares traded.Over the past week, the price has changed by +1.32%, over one month by +2.48%, over three months by +7.64% and over the past year by +22.50%.
Is Global X Enhanced S&P/TSX a good stock to buy?
Yes. Based on ValueRay's Analyses, Global X Enhanced S&P/TSX (TO:CNCL) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 60.95 and therefor a clear technical positive rating according to historical growth.Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNCL is around 22.93 CAD . This means that CNCL is currently undervalued and has a potential upside of +10.24% (Margin of Safety).
Is CNCL a buy, sell or hold?
Global X Enhanced S&P/TSX has no consensus analysts rating.What are the forecasts/targets for the CNCL price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.5 | 22.5% |
CNCL Fundamental Data Overview
Market Cap CAD = 16.6m (16.6m CAD * 1.0 CAD.CAD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CAD
Beta = 0.0
Revenue TTM = 0.0 CAD
EBIT TTM = 0.0 CAD
EBITDA TTM = 0.0 CAD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 16.6m CAD (16.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 16.6m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 16.6m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(16.6m)/V(0.0) * Re(8.11%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)